DrugPatentWatch Database Preview

Acorda Company Profile

« Back to Dashboard

What is the competitive landscape for ACORDA, and when can generic versions of ACORDA drugs launch?

ACORDA has one approved drug.

There are six US patents protecting ACORDA drugs.

There are forty-six patent family members on ACORDA drugs in twenty-three countries and twenty-three supplementary protection certificates in ten countries.

Summary for Acorda

International Patents:	46
US Patents:	6
Tradenames:	1
Ingredients:	1
NDAs:	1
Patent Litigation for Acorda:	See patent lawsuits for Acorda
PTAB Cases with Acorda as patent owner:	See PTAB cases with Acorda as patent owner

Drugs and US Patents for Acorda

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Acorda	AMPYRA	dalfampridine	TABLET, EXTENDED RELEASE;ORAL	022250-001	Jan 22, 2010	AB	RX	Yes	Yes	9,918,973
Acorda	AMPYRA	dalfampridine	TABLET, EXTENDED RELEASE;ORAL	022250-001	Jan 22, 2010	AB	RX	Yes	Yes	8,663,685
Acorda	AMPYRA	dalfampridine	TABLET, EXTENDED RELEASE;ORAL	022250-001	Jan 22, 2010	AB	RX	Yes	Yes	8,007,826
Acorda	AMPYRA	dalfampridine	TABLET, EXTENDED RELEASE;ORAL	022250-001	Jan 22, 2010	AB	RX	Yes	Yes	8,440,703
Acorda	AMPYRA	dalfampridine	TABLET, EXTENDED RELEASE;ORAL	022250-001	Jan 22, 2010	AB	RX	Yes	Yes	5,540,938
Acorda	AMPYRA	dalfampridine	TABLET, EXTENDED RELEASE;ORAL	022250-001	Jan 22, 2010	AB	RX	Yes	Yes	8,354,437

Expired US Patents for Acorda

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Acorda	AMPYRA	dalfampridine	TABLET, EXTENDED RELEASE;ORAL	022250-001	Jan 22, 2010	5,370,879
Acorda	AMPYRA	dalfampridine	TABLET, EXTENDED RELEASE;ORAL	022250-001	Jan 22, 2010	5,540,938

Paragraph IV (Patent) Challenges for ACORDA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Extended-release Tablets	10 mg		2014-01-22

International Patents for Acorda Drugs

Country	Document Number	Estimated Expiration
Japan	5736100
Mexico	PA06011648
Croatia	P20130424
Portugal	2377536
Japan	2012188427
Japan	2012188427
Spain	2367707

Supplementary Protection Certificates for Acorda Drugs

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0033	France		PRODUCT NAME: FAMPRIDINE OU L'UN DE SES DERIVES; REGISTRATION NO/DATE: EU/1/11/699/001-002 20110725
0612	Netherlands		PRODUCT NAME: 4-AMINOPYRIDINE, DAN WEL EEN DERIVAAT DAARVAN, IN HET BIJZONDER EEN ZOUT, SOLVAAT OF PRODRUG; REGISTRATION NO/DATE: EU/1/11/699/001-002 20110720
/2013	Austria		PRODUCT NAME: 4-AMINOPYRIDIN ODER DESSEN SALZE; REGISTRATION NO/DATE: EU/1/11/699/001-002 20110720
2012001	Lithuania		PRODUCT NAME: FAMPRIDINUM; REGISTRATION NO/DATE: EU/1/11/699/001 - EU/1/11/699/002 20110720
0120002 00051	Estonia		PRODUCT NAME: FAMPYRA - FAMPRIDINE;REG NO/DATE: C(2011)5390 FINAL 20.07.2011
90033-9	Sweden		PRODUCT NAME: 4-AMINOPYRIDIN ELLER ETT SALT DAERAV; REG. NO/DATE: EU/1/11/699/001 20110720
2013015,C2377536	Lithuania		PRODUCT NAME: FAMPRIDINUM; REGISTRATION NO/DATE: EU/1/11/699/001 - EU/1/11/699/002 20110720

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Acorda